
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Pharmacology/Toxicology
Study Phase : Undisclosed
Sponsor : ActoPharma
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Erdal Can Alkoclar to Renew Antiviral License for ActoPharma
Details : The biopharmaceutical formulation consisting of two flavanol glycoside analogues is designed to simultaneously reduce viral load, decrease platelet aggregation and modulate the cytokine ratios in order to effectively suppress cytokine storm.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
January 26, 2021
Lead Product(s) : Undisclosed
Therapeutic Area : Pharmacology/Toxicology
Highest Development Status : Undisclosed
Sponsor : ActoPharma
Deal Size : Undisclosed
Deal Type : Licensing Agreement
